Research Engineer - Novel therapeutic strategies to treat liver cancer

id="offer-description" class="ecl-u-type-heading-2 ecl-u-mt-none ecl-u-mb-l">Offer Description The Institute for Translational Medicine and Liver Disease (ITM), Inserm U1110, University of Strasbourg France, is looking for a research engineer (ingénieur•e de recherche, IR) to join our translational liver disease and cancer program . The program is focussed to unravel novel strategies to treat hepatobiliary fibrosis and liver cancer with a focus on proof-of-concept studies in mouse models. Key scientific discoveries relevant to this offer are described in: Mailly et al. Nature Biotech 2015, Hamdane et al. Gastroenterology 2019, Juehling et al. Gut 2021, Crouchet et al. Nat. Commun. 2021, Roehlen et al. Science Transl. Med 2022, Roehlen et al. J. Hepatol. 2023, Del Zompo et al. J Hepatol 2025, Saviano et al. Nature Reviews Cancer 2026, Slovic et al. Hepatology 2026, Crouchet et al., JCI 2025; Nehme et al. Science Transl. Med 2026. What we offer . The institute is a world-class organisation of scientific excellence, training, and innovation in the heart of Europe within a high-quality environment of pharma, academia, and medical care. The successful candidate will benefit from: . An international and vibrant state-of-the-art training environment in biomedical research . Cutting-edge technologies including animal model laboratory, sc/snRNA and spatial transcriptomics, patient-derived models, systems biology and AI platforms . Close collaborations with pharma and world-class leadi